Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Latest News about ABBV

Recent news which mentions ABBV

< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
32 33 Next >
Blue Shield of California Slashes Humira Biosimilar Prices in Landmark Deal
Tickers ABBV NEWS UNH
Tags Briefs General News
From Benzinga
Comparing AbbVie With Industry Competitors In Biotechnology Industry
Tickers ABBV NEWS
Tags ABBV Benzinga Market News
From Benzinga
Behind the Scenes of AbbVie's Latest Options Trends
Tickers ABBV
Tags Options Markets BZI/UOA
From Benzinga
Medicare Drug Price Negotiation Program Gets Final Guidance For Second Cycle, $1.5B Savings Expected
Tickers ABBV GSK NEWS NVO
Tags Benzinga Biotech Market News
From Benzinga
5 Best Dividend Growth Stocks to Buy in October
Tickers ABBV AXP BAC COST
Tags Recent Press Releases COST ABBV
From Motley Fool
Meta, Accenture, Disney And A Major Health Care Stock On CNBC's 'Final Trades'
Tickers ABBV ACN DIS META
Tags Markets ACN Long Ideas
From Benzinga
(ABBV) - Analyzing AbbVie's Short Interest
Tickers ABBV
Tags BZI/SHORTHIST Short Sellers Trading Ideas
From Benzinga
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
Tickers ABBV BMY NEWS
Tags Top Stories Trading Ideas Health Care
From Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Tickers ABBV NEWS
Tags BZI/POD Trading Ideas ABBV
From Benzinga
AbbVie Says Pivotal Trial For Parkinson's Candidate Meets Its Primary Goal In Patients With Early Disease
Tickers ABBV NEWS
Tags Benzinga Biotech ABBV
From Benzinga
Forget Novo Nordisk, Buy This Magnificent Dividend Stock Instead
Tickers ABBV NVO
Tags NVO ABBV Market News
From Motley Fool
Behind the Scenes of AbbVie's Latest Options Trends
Tickers ABBV
Tags ABBV Benzinga Market News
From Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
Tickers ABBV BMY NEWS
Tags Stories That Matter Top Stories Health Care
From Benzinga
Spotlight on AbbVie: Analyzing the Surge in Options Activity
Tickers ABBV
Tags Market News Benzinga ABBV
From Benzinga
Competitor Analysis: Evaluating AbbVie And Competitors In Biotechnology Industry
Tickers ABBV NEWS
Tags Trading Ideas BZI/IA Markets
From Benzinga
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Tickers ABBV AZN
Tags ABBV AZN Recent Press Releases
From Motley Fool
TransDigm, BJ's Wholesale, AbbVie And More On CNBC's 'Final Trades'
Tickers ABBV BJ NEWS SMH
Tags ABBV Media News
From Benzinga
Can AbbVie Regain Its Status As a Top Dividend Growth Stock?
Tickers ABBV ABT
Tags ABT ABBV Market News
From Motley Fool
Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More
Tickers ABBV MRNA
Tags ABBV ZLDP/F Market News
From Motley Fool
3 Stocks to Buy and Hold Forever
Tickers ABBV ABT LLY VRTX
Tags Market News LLY Recent Press Releases
From Motley Fool
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Tickers ABBV BIP BIPC VZ
Tags BIPC Recent Press Releases BIP
From Motley Fool
< Previous 1 2
...
12 13 14 15 16 17 18 19 20
...
32 33 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.